IL25 and neoplasm: Although the development of primary tumor (Fig. 2A) and the survival rate (Fig. S2) of MMTV-PyMT mice were not altered, anti-IL-25 antibody treatment reduced lung metastasis by >60%, as determined by the numbers of tumor nodes (Fig. 2B).